baber/WOPTO huggingface dataset:
Patent CA-2701559-A1 (CA)
Title: High strength part and method of production of the same
Inventor: KUSUMI KAZUHISA
IPC: C21D1/74
Filed: 2005-09-15
Abstract: A high-strength part that excels in hydrogen embrittlement resistance and strength after high-temperature forming; and a process for producing the same. The atmosphere in a heating furnace before forming is regulated to one of <= 10% hydrogen volume fraction and <= 30°C dew point. As a result, the amount of hydrogen penetrating in a steel sheet during heating is reduced. After forming, there are sequentially carried out quench hardening in die assembly and post-working. As the method of post-working, there can be mentioned shearing followed by re-shearing or compression forming of sheared edge portion; punching with a cutting blade having a gradient portion at which the width of blade base is continuously reduced; punching with a punching tool having a curved blade with a protrudent configuration at the tip of cutting blade part, the curved blade having a shoulder portion of given curvature radius and/or given angle; fusion cutting; etc. Consequently, the tensile residual stress after punching is reduced and the performance of hydrogen embrittlement resistance is improved.
Patent CA-2702362-A1 (CA)
Title: Improved system and method for patient temperature control
Inventor: CARSON GARY
IPC: A61F7/00
Filed: 2008-10-13
Abstract: A patient temperature control system and method are provided for automated temperature control according to a programmed protocol. In one aspect, at least one programmed protocol may be established for each of a plurality of patient thermal therapy phases. The programmed protocol controls, at least in part, the temperature of a thermal exchange medium during each phase. In another aspect, a plurality of programmed protocols may be established, wherein a selected one of the protocols may be utilized for automated temperature control during patient thermal therapy. The protocol(s) may include a target patient temperature and/or a set duration for one or more phases.  Further, the protocol(s) may be user-definable and modifiable during therapy. In a multiphase configuration, automatic termination and initiation of specific phases may be selectively established by a user, based on target patient temperature data and/or set duration data.
Patent CA-2703582-A1 (CA)
Inventor: TIRPAK THOMAS M
IPC: G06F9/34
Filed: 2008-10-23
Abstract: A hierarchical decoder is operable to decode a hierarchical multi-layer data package. The hierarchical multi-layer data package includes a plurality of layers and one or more subpackages in each layer. To decode the data package, an objective function is created based on parameters for identifying data in the data package most relevant to information of interest. Subpackages in one or more layers are evaluated using the objective function and a subpackage is selected. Information for the selected subpackage, which may include a summary and metadata, is used to determine whether the subpackage satisfies an information need. If the information need is not satisfied, a drill down procedure is performed to evaluate subpackages in a next lower layer of the data package.
Patent CA-2705763-A1 (CA)
Inventor: JEANNETEAU LAURENT
IPC: F24C15/10
Filed: 2008-10-08
Abstract: The present invention relates to a method for controlling a cooking device, in particular an induction hob. The method comprises the steps of activating an overload power (P OVER) for at least one electric or electronic component of the cooking device by using at least two synchronized generators, which overload power (P  OVER) is greater than a standard maximum power (P MAX), deactivating the overload power (P OVER) after a predetermined period (.DELTA.t), and operating the cooking device at a power (P), which is at most the standard maximum power (P MAX) .cndot. The standard maximum power (P MAX) is provided for a permanent operation of the cooking device. The overload power (P OVER) and/or the period (.DELTA.t) are determined by a function depending on at least the overload power (P OVER) and the period (.DELTA.t). The present invention relates further to a corresponding apparatus for controlling a cooking device, in particular an induction hob.
Patent CA-2707180-A1 (CA)
Title: Preparation of a potassium phosphate based composition
Inventor: JOSEF ALEXANDER
IPC: C05B17/00
Filed: 2008-11-13
Abstract: Provided is a freely flowing particulate fertilizer essentially consisting of potassium phosphate of the formula K3H3(P04)2 and of less than 8 wt% water. The stable and not caking fertilizer is characterized by an XRD signal corresponding to 2-theta of about 70°. An economic process for making the fertilizer is also provided consisting in reacting KOH and monopotassium phosphate (KH2P04) in water, heating the mixture under vacuum and cooling it down, thereby obtaining the particulate fertilizer.
Patent CA-2709783-A1 (CA)
Title: Guide tube equipped with balloon for puncture
Inventor: OISHI HIDETO
IPC: A61F2/958
Filed: 2007-12-18
Abstract: It is intended to provide a guide tube having balloons for puncture which comprises a main body tube (1) having a balloon on the surface in the tip side, wherein the balloon on the surface of the tip side as described above is provided as an outer balloon (2), a needle through hole, through which a puncture needle (22) passes, is formed in the wall of the main body tube (1) located inside the outer balloon (2), this hole is air-tightly blocked with an inflatable sheet material, and this sheet material is provided as an inner balloon (9). When the outer balloon (2) is inflated, the inner balloon (9) is inflated and projects from the needle through hole toward the inside of the main lumen (5) due to the inner pressure of the outer balloon (2), which makes it possible to pierce the tip of the puncture needle (22) into the projected area. Thus, a deeper puncture can be ensured and a transdermal approach route into the body can be safely and surely formed.
Patent CA-2711084-A1 (CA)
Inventor: GRIFFIN DAVID C
IPC: H05H1/34
Filed: 2010-07-23
Abstract: A plasma arc torch is provided that includes a wear stop designed to detect wear of an electrode and prevent the use of the electrode once the electrode has experienced a certain amount of wear. Either the electrode or the nozzle is movable with respect to the main torch body, and the movable component defines a projection. The wear stop is positioned a predetermined distance from a nozzle of the torch, such that prior to experiencing an excessive amount of wear, the electrode is able to contact the nozzle and initiate a pilot arc for starting a torch operation. Once the length of the electrode becomes shorter than a predetermined length due to wear, the projection of the electrode engages the wear stop, and the wear stop prevents the electrode from contacting the nozzle. In this way, an electrode that is excessively worn cannot be used in subsequent torch operations.
Patent CA-2711480-A1 (CA)
Inventor: BECKER BJOERN EDUARDO
IPC: B32B5/22
Filed: 2009-01-05
Abstract: A studded plate (1) of layer (2) of a polymeric material where an adhesive material (3,4) in the form of a vo wen or non-vowen material is attached on each side of the layer (2).
Patent CA-2716901-A1 (CA)
Inventor: HOWES SIMON A M
IPC: A61K9/10
Filed: 2009-02-26
Abstract: The commercial formulation of fast dispersing dosage forms (FDDF) requires substantial holding times during which large quantities of pharmaceutically active substance are formed into individual dosage units. During this holding time, pharmaceutical agents with a propensity to polymorphism in an aqueous environment may crystallize into various, and sometimes unpredictable forms. These crystalline forms may affect the efficacy of the pharmaceutical agent. Previous attempts to control this process have included attempts to direct crystallization into a stable form.  The instant invention acts to suppress crystallization, by utilizing a combination of standard molecular weight fish gelatin and a low processing temperature, to suppress crystallization to a degree that is not accomplished by either the use of standard molecular weight fish gelatin or low processing temperatures individ-ually.
Patent CA-2717612-A1 (CA)
Inventor: AGGARWAL GAURAV
IPC: G06K9/00
Filed: 2009-04-13
Abstract: Techniques for generating a gradient characterization for a first fingerprint image are provided. One or more fingerprint feature points are selected from the first fingerprint image. A  region is obtained for each of the one or more selected fin-gerprint feature points. The region is a representation of an area proximate a given fingerprint feature point. Each of the obtained regions is divided into a plurality of sub-regions. A histogram is generated for each of the plurality of sub-regions. For each of the one or more selected fingerprint feature points, the one or more generated histograms are combined into a concatenated histogram.  The concatenated histogram is used for identification purposes.
Patent CA-2717631-A1 (CA)
Inventor: SABETA ANTON
IPC: G02C13/00
Filed: 2010-10-14
Abstract: A method for tracking ophthalmic lens care compliance, said method comprising the steps of; including at least one sensor with said ophthalmic product for monitoring at least one ambient condition and for logging and recording at least one reading associated said at least one ambient condition, following a predetermined event;  determining whether said at least one reading exceeds at least one predetermined threshold, and issuing an alert when said at least one reading exceeds at least one predetermined threshold.
Patent CA-2717872-A1 (CA)
Inventor: KOLETZKO WOLFRAM
IPC: B64C25/10
Filed: 2010-10-15
Abstract: The invention relates to an undercarriage for a rotary wing aircraft, the undercarriage including a tubular structure with skids, said tubular structure being designed to be mounted under or in a bottom portion of the aircraft, the undercarriage being characterized in that the tubular structure comprises left and right longitudinal portions that are retractable, each of which portions is suitable for moving between a retracted position in a cruising flight configuration and a deployed configuration in a landing configuration.
Patent CA-2718419-A1 (CA)
Inventor: CLIFFORD CHARLES B
IPC: A01K67/027
Filed: 2009-03-06
Abstract: The invention is directed to a hairless, immunodeficient mouse that is homozygous recessive for a hairless (Hr hr) allele and both B-cell deficient and T-cell deficient. The B-cell and T-cell deficiency is attributed to a homozygous recessive scid allele (Prkdc scid) a homozygous recessive beige allele (Lyst bg), or a mutated Rag allele. These mice offer an advantage over nude mouse models used in cancer research because they can be maintained as homozygous breeding pairs and they have greater immune deficits, which permit better growth of xenogenic tumor lines, and rapid assessment of cutaneous and subcutaneous tumors and tissue grafts.
Patent CA-2719110-A1 (CA)
Inventor: NEWMAN CRAIG
IPC: A61M5/32
Filed: 2009-03-13
Abstract: A safety needle assembly is provided herein which includes a hub; a needle fixed to the hub, the needle having a dista! end, formed for insertion into a patient, and a proximal end; a first shield having a tubular body at least partially encircling a portion of the needle, wherein in an initial state, the first shield extends from the hub; a second shield having a tubular body at least partially encircling a portion of the needle; a biasing element disposed to urge the second shield distally towards the distal end of the needle; and, a releasable retaining arrangement for releasably retaining the second shield in a first state. Upon a predetermined extent of proximal movement of the first shield relative to the hub, the second shield is released thereby allowing the biasing element to urge the second shield to a second state in which the dista.i end of the needle is covered. Advantageously, with the arrangement of the subject invention, two shields are provided for at least partially covering a needle with one of the shields acting as a trigger.
Patent CA-2722446-A1 (CA)
Inventor: GRASBERGER BRUCE L
IPC: C12Q1/44
Filed: 2009-04-24
Abstract: A number of soluble engineered forms of MGLL that are suitable for high-throughput screening and protein crys-tallization, as well as a crystallized form of monoacylglycerol lipase protein (MGLL) and descriptions of the X-ray diffraction pat-terns are disclosed. The engineered constructs of MGLL permit the expression and purification of protein suitable for crystallogra-phy or high-throughput screening and identification of ligands, which can function as active agents to MGLL. The X-ray diffrac-tion patterns allow the three dimensional structure of MGLL to be determined at atomic resolution so that ligand binding sites on MGLL can be identified and the interactions of ligands with MGLL amino acid residues can be modeled. Models prepared using such maps permit the design of ligands which can function as active agents which include, but are not limited to, those that func-tion as inhibitors of MGLL.
Patent CA-2722481-A1 (CA)
Inventor: FRESKO NEDIM
IPC: G06F9/44
Filed: 2009-06-29
Abstract: An improved application development tool that enables the creation of an application and provides for the creation of additional context-sensitive menu items by structuring the application to be executed on a platform having a feature wherein a menu of selectable functions is output in response to a predetermined input by incorporating a first instruction into a template in-struction set to generate a class of instructions which, when executed on the platform, is structured to cause an additional se-lectable function that is specified by the first instruction to be output in the menu responsive to the predetermined input.
Patent CA-2723277-A1 (CA)
Inventor: HASTEWELL JOHN
IPC: C07K14/78
Filed: 2009-05-04
Abstract: The invention provides fibronectin type III (Fn3)-based binding molecules that bind to a specific target antigen.  The invention further provides bispecific Fn3 -based binding molecules that bind to two or more targets simultaneously. The Fn3-based binding molecules of the invention can also be linked together to form multispecific Fn3-based binding molecules, and/or can be conjugated to a non-Fn3 moiety, such as, Human Serum Albumin (HSA), for improved half life and stability. The invention also provides methods for generating, screening and using Fn3 -based binding molecules in a variety of therapeutic and diagnostic applications.
Patent CA-2728474-A1 (CA)
Inventor: BEIER CHRISTIAN
IPC: A01N43/78
Filed: 2009-07-03
Abstract: The present invention relates to hydroximoyl-tetrazole derivatives of formula (I), their process of preparation, their use as fungicide active agents, particularly in the form of fungicide compositions and methods for the control of phytopathogenic fungi, notably of plants, using these compounds or compositions, wherein A  represents a tetrazoyl group, Het represents a pyridyl group or a thiazolyl group and X represents various substituents.
Patent CA-2729064-A1 (CA)
Inventor: SEWELL NORMAN
IPC: F24C15/10
Filed: 2011-01-24
Abstract: An adjustable foot assembly for a pan support of a home appliance is provided.    The assembly includes a first bushing having an inside threaded surface on an inner surface, and outside threaded surface on an outer surface; a set screw having an outside threaded surface on an outer surface, the outside threaded surface of the set screw engaging the inside threaded surface of the first bushing such that the set screw is movable relative to the first bushing along a first direction; and a contact foot attached to the first bushing. The first bushing and the set screw are adapted to allow the set screw to be moved relative to the first bushing as the set screw is moved into contact with the pan support, the relative movement being allowed by the outside threaded surface of the set screw moving relative to the inside threaded surface of the first bushing.
Patent CA-2732449-A1 (CA)
Title: Fgfr extracellular domain acidic region muteins
Inventor: MARSHALL SHANNON
IPC: C12N15/12
Filed: 2009-08-04
Abstract: Fibroblast growth factor receptor (FGFR) extracellular domain (ECD) acidic region muteins that have been engineered to exhibit decreased tissue binding by increasing the number of acidic amino acid residues within the D1 -D2 linker region are provided. Polynucleotides encoding FGFR ECD acidic region muteins are also provided. Methods of making FGFR ECD  acidic region muteins, and methods of using such molecules to treat proliferative disorders, including cancers, disorders of angiogenesis, and macular degeneration, are also provided.
Patent CA-2733055-A1 (CA)
Title: Geocell for load support applications
Inventor: HALAHMI IZHAR
IPC: E02D3/00
Filed: 2008-09-29
Abstract: A geocell is disclosed that has high strength and stiffness, such that the geocell has a storage modulus of 500 MPa or greater at 23°C; a storage modulus of 150 MPa or greater at 630C  when measured in the machine direction using Dynamic Mechanical Analysis (DMA) at a frequency of 1 Hz; a tensile stress at 12%  strain of 14.5 MPa or greater at 230C; a coefficient of thermal expansion of 120 x 10'6 /0C or less at 250C, and/or a long term design stress of 2.6 MPa or greater. The geocell is suitable for load support applications, especially for reinforcing base courses and/or subbases of roads, pavement, storage areas, and railways.
Patent CA-2735347-A1 (CA)
Title: Co2 refrigeration system for ice-playing surface
Inventor: DUBE SERGE
IPC: F25C3/02
Filed: 2011-03-28
Abstract: A CO2 refrigeration system for an ice-playing surface comprises a transfer circuit, a CO2 refrigerant circuit and an independent condensation circuit. A transfer refrigerant circulates in the transfer circuit between a condensation heat exchanger and an evaporation heat exchanger. The CO2 circuit is in heat-exchange relation with the condensation heat exchanger to release heat from the CO2 refrigerant. The CO2 circuit comprises a condensation reservoir to accumulate the CO2 refrigerant, and an evaporation stage to receive the CO2 refrigerant from the condensation reservoir to absorb heat from the ice-playing surface. The independent circuit is in heat-exchange relation with the refrigerant of the transfer circuit at the evaporation heat exchanger. The independent circuit comprises a compression stage with a magnetically operated compressor to compress a secondary refrigerant, a condensation stage in which the secondary refrigerant releases heat, and an evaporation stage in which the secondary refrigerant is in heat-exchange relation with the transfer refrigerant at the evaporation heat exchanger to absorb heat.
Patent CA-2735498-A1 (CA)
Inventor: BERTRAM RICHARD DAVID
IPC: C10M141/06
Filed: 2011-03-30
Abstract: A lubricating oil composition having a phosphorus content of up to 0.12 wt%, a sulfated ash content of up to 1.2 wt% comprising (a) a major amount of an oil of lubricating viscosity; (b) an alkali metal or alkaline earth metal alkyl salicylate lubricating oil detergent providing from 7-15 mmol salicylate soap per kilogram of lubricating oil composition; (c) one or more dispersants providing the lubricating oil composition with from at least 0.12 wt% to 0.20 wt% atomic nitrogen, based on the weight of the lubricating oil composition, and (d) a dispersant-viscosity modifier.
Patent CA-2736955-A1 (CA)
Title: Multiheteroaryl compounds as inhibitors of h-pgds and their use for treating prostaglandin d2 mediated diseases
Inventor: ENDRES GREGORY W
IPC: C07D403/14
Filed: 2009-09-22
Abstract: Multiheteroaryl compounds, their preparation, pharmaceutical compositions comprising these compounds, and their pharmaceutical use in the prevention and treatment of prostaglandin D2 mediated diseases and conditions that may be modulated by the inhibition of hematopoietic prostaglandin D synthase (H-PGDS).
Patent CA-2737462-A1 (CA)
Inventor: WASSON MATTHEW HOWARD
IPC: A61F13/20
Filed: 2009-09-21
Abstract: Wrappers having cord reservoirs are provided. A feminine device having an insertion end, a withdrawal end, and a withdrawal member, the withdrawal member having a proximal end nearest the withdrawal end of the feminine device and a distal end disposed opposite the proximal end is provided. The feminine device can be at least partially enclosed by a wrapper. The wrapper can have a first end disposed adjacent to the insertion end, a second end opposite the insertion end, and a longitudinal axis. In certain embodiments, the wrapper can have a cord reservoir at the second end of the wrapper, the cord reservoir being adapted to contain at least a portion of the withdrawal member within the cord reservoir. In addition, the cord reservoir can have a length measured along the longitudinal axis from the distal end of the feminine device to the second end of the wrapper of at least about 1 mm.
Patent CA-2737762-A1 (CA)
Title: Implantable prosthetic valve
Inventor: SPENSER BENJAMIN
IPC: A61F2/24
Filed: 2002-10-11
Abstract: A valve prosthesis device suitable for implantation in body ducts, the device comprising an expandable support frame adapted to be initially crimped in a narrow configuration suitable for catheterization through the body duct to a target location and configured to be expanded to an expanded configuration in the target location, the support frame being provided with a plurality of longitudinally rigid support beams of fixed length; and a valve assembly comprising a flexible conduit having an inlet and an outlet, made of pliant material attached to the support beams providing collapsible slack portions of the conduit at the outlet, whereby when flow is allowed to pass through the valve prosthesis device from the inlet to the outlet the valve assembly is kept in an open position, whereas a reverse flow is prevented as the collapsible slack portions of the valve assembly collapse inwardly providing blockage to the reverse flow, characterized in that the support beams are provided with bores, the valve assembly is stitched to the support beams with thread or fiber through the bores and the outlet is tapered with respect to the inlet and the support frame at the outlet is wider in diameter than the pliant material forming the outlet.
Patent CA-2739732-A1 (CA)
Inventor: AMAN AHMED
IPC: A23L27/40
Filed: 2009-11-13
Abstract: The current application relates to organic nutrient salts comprised of 3-amino-1-propanesulfonic acid (homotaurine) and an organic cationic component which contributes to the therapeutic and/or nutritional value of the salts. The application also relates to the method of preparing the organic nutrient salts and the use of the same as nutraceuticals for neuroprotection and for improving or protecting cognitive and memory functions.
Patent CA-2741571-A1 (CA)
Title: Expandable eyewear with snap-together bridge
Inventor: LANDO RON
IPC: G02C5/02
Filed: 2010-06-01
Abstract: The present eyewear includes a pair of lenses, a pair of releaseable connectors connected to respective inner ends of the lenses, a pair of temples pivotally connected to respective outer ends of the lenses and a rigid strap connected between rear ends of the temples. The strap is generally U-shaped having substantially parallel legs connected to an arc-shaped base, the substantially parallel legs being connected to rear ends of the temples and when worn, the arc-shaped base extends along the back of a user's head.  The strap at its U-shaped base is provided with a telescoping segment for selectively altering the length of the arc-shaped base for altering the spacing between the strap's substantially parallel legs to adjust the strap for varying widths of a user's head. The inner ends of the lenses are releaseably secured together by connectors. In use, the lenses are separated from each other and pivoted outwardly, the strap wrapped around the back of a user's head and adjusted for size. The lenses are then pivoted towards each other and secured together in front of the user's eyes. The lenses are instantly separable for easily putting on or taking off the eyewear, but they are instantly connectable together for a secure and accurate fit.